Skip to content

Search

Search managers or tickers

Hillman Capital

Q2 2021 13F · by Mark Hillman, CIO

As of
Jun 30, 2021
Filed
Aug 16, 2021
US stock
$263M · prev $228M
Positions
48 · prev 43
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves44 since the prior filing

The book

Focused · behaves like 33 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Low turnover · 0.5% a year, more than 30 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions19% of US stock

  1. WFC Wells Fargo & Co. trimmed+0.02 pp trimmed+0.024.0%
  2. AMZN Amazon.Com Inc added+0.56 pp added+0.563.9%
  3. XOM Exxon Mobil Corp added−0.05 pp added−0.053.8%
  4. SPG Simon Property Group, Inc. added+0.34 pp added+0.343.8%
  5. PAA Plains All American Pipeline, L.P. Common Units representing Limited Partner Interests added+0.30 pp added+0.303.7%

Positions48 in this filing · 0 exited

WFCWells Fargo & Co.3.97%230,258$10Mtrimmed−0%+0.02 pp7 q
AMZNAmazon.Com Inc3.91%2,988$10Madded+21%+0.56 pp2 q
XOMExxon Mobil Corp3.79%157,854$10Madded+1%−0.05 pp7 q
SPGSimon Property Group, Inc.3.76%75,803$10Madded+11%+0.34 pp7 q
PAAPlains All American Pipeline, L.P. Common Units representing Limited Partner Interests3.72%861,125$10Madded+1%+0.30 pp6 q
BIIBBiogen Inc.3.59%27,239$9Mtrimmed−0%+0.24 pp7 q
KHCThe Kraft Heinz Company3.56%229,675$9Madded+7%−0.20 pp7 q
unresolvedGlaxosmithkline PLC3.54%233,575$9Madded+1%−0.09 pp3 q
BUDAnheuser-Busch INBEV SA/NV3.52%128,521$9Madded+1%0.00 pp7 q
CVSCvs Health Corporation3.46%108,929$9Madded+1%−0.11 pp7 q
TAT&T Inc.3.41%311,034$9Madded+25%+0.11 pp7 q
KELKellanova3.38%138,108$9Madded+2%−0.38 pp7 q
MSFTMicrosoft Corp3.38%32,769$9Madded+3%+0.08 pp7 q
BABoeing Company3.08%33,736$8Madded+1%−0.67 pp5 q
DDDuPont de Nemours, Inc.3.02%102,478$8Madded+1%−0.43 pp7 q
BMYBristol-Myers Squibb Co.3.00%118,057$8Madded+1%−0.24 pp7 q
EPDEnterprise Products Partners L.P.3.00%326,491$8Madded+1%−0.13 pp7 q
CMPCompass Minerals International, Inc.2.88%127,613$8Madded+22%−0.01 pp7 q
MRKMerck & Co., Inc.2.83%95,557$7Madded+41%+0.53 pp7 q
DISCADiscovery, Inc. Series A2.75%235,326$7Mnew+2.75 ppnew
INTCIntel Corp2.72%127,453$7Madded+6%−0.65 pp7 q
METAMeta Platforms, Inc. Class A2.71%20,511$7Mtrimmed−0%+0.06 pp7 q
GOOGLAlphabet Inc. Class A2.69%2,900$7Mtrimmed−3%−0.02 pp2 q
PFEPfizer Inc.2.52%169,105$7Madded0%−0.16 pp7 q
RTXRTX Corporation2.38%73,339$6Mheld—5 q
BDXBecton, Dickinson and Co.2.35%25,443$6Madded0%−0.36 pp6 q
GDGeneral Dynamics Corporation2.32%32,339$6Mtrimmed−0%−0.26 pp4 q
VZVerizon Communications2.31%108,294$6Madded0%−0.45 pp7 q
CSCOCisco Systems, Inc. (DE)2.30%114,012$6Madded0%−0.28 pp4 q
BNYBank of New York Mellon Corporation2.20%112,875$6Mtrimmed−0%−0.14 pp3 q
WEPMagellan Midstream Partners2.18%117,344$6Mheld—2 q
99803EURLaboratory Crp Of Amer Hldgs1.99%18,954$5Mtrimmed−0%−0.14 pp7 q
EMREmerson Electric Co.1.20%32,676$3Mtrimmed−0%−0.09 pp7 q
LMTLockheed Martin Corp.0.97%6,752$3Madded+2%−0.10 pp3 q
EFAiShares MSCI EAFE ETF0.48%15,908$1Madded+6%−0.02 pp7 q
MDTMedtronic plc0.16%3,356$417,000added+1%−0.01 pp7 q
GOOGAlphabet Inc. Class C0.11%115$288,000trimmed−2%0.00 pp3 q
NOWServicenow, Inc.0.11%506$278,000new+0.11 ppnew
CRMSalesforce, Inc.0.10%1,085$265,000new+0.10 ppnew
KOCoca-Cola Company0.09%4,581$248,000added+6%−0.01 pp3 q
CMCSAComcast Corp0.09%4,140$236,000trimmed−0%−0.01 pp3 q
STZConstellation Brands, Inc.0.09%1,046$245,000added+2%−0.01 pp3 q
unresolvedGeneral Electric Co0.09%18,379$247,000added+2%−0.01 pp7 q
MARMarriott International Class A0.09%1,680$229,000held—3 q
MMM3M Company0.09%1,229$244,000held—3 q
IWRiShares Russell Mid-Cap ETF0.08%2,569$204,000trimmed−0%0.00 pp7 q
IJRiShares Core S&P Small-Cap ETF0.02%424$48,000new+0.02 ppnew
AGGiShares Core U.S. Aggregate Bond ETF0.01%281$32,000new+0.01 ppnew

Source

Form
13F-HR
Reading
0 defects · 2 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet